Promensil
Natural health product licensed in Canada
- Licence holder
- PAC Health (Canada) Inc.
- NPN or DIN-HM
- 80015467
- Status
- Active licence
- Licence date
- 26 January 2010
- Revision date
- 17 June 2022
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Cire de Carnauba, Macrogol 400, Huile de fève de soja, Gum acacia, Stéarate de magnésium, Hydrogénophosphate de calcium, Oxydes de fer, Colloidal silicon dioxide, Hypromellose, mélange de tocophérols, Croscarmellose de sodium, Microcrystalline cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | Not specified | 1 Comprimé | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
May reduce severe and frequent menopausal symptoms (such as hot flashes/flushes and/or night sweats. Helps to reduce Bone Mineral Density losses with adequate intake of calcium and vitamin D in post-menopausal women. May/helps support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80015467
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging